Medtronic plc (MDT)

79.64 +0.27 (+0.34%) At close: 04:00PM EDT

Medtronic plc

20 On Hatch
Lower Hatch Street
Dublin 2
Ireland
353 1 438 1700
https://www.medtronic.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 95,000

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Geoffrey Straub Martha	Chairman & CEO	4.35M	1.63M	1970
Ms. Karen L. Parkhill	EVP, CFO, IT & Enterprise Excellence	2.41M	N/A	1965
Mr. Ivan K. Fong	Exec. VP, Gen. Counsel & Sec.	985.57k	N/A	1961
Mr. Robert J. W. ten Hoedt	Exec. VP & Pres of Global Regions	2.02M	N/A	1960
Mr. Robert John White	Exec. VP & Pres of Medical Surgical Portfolio	2M	N/A	1963
Mr. Mark Ploof	Sr. VP of Global Operations and Bus. Services	N/A	N/A	N/A
Ms. Jennifer M. Kirk	Principal Accounting Officer, Global Controller & Chief Accounting Officer	N/A	N/A	1975
Dr. Laura Mauri M.D., M.Sc.	Sr. VP and Chief Scientific, Medical & Regulatory Officer	N/A	N/A	N/A
Mr. Sean Lennon	Chief Information Officer	N/A	N/A	N/A
Mr. Ryan Weispfenning	VP of Investor Relations	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Corporate governance

Medtronic plc’s ISS governance QualityScore as of 1 February 2023 is 6. The pillar scores are Audit: 8; Board: 4; Shareholder rights: 6; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.